Vitamin D deficiency in children: A review on prevention and treatment strategy
DOI:
https://doi.org/10.3329/icpj.v5i1.25870Keywords:
Vitamin D, children, Chinese, non-skeletal disorders, prevention, pediatricAbstract
As an essential fat-soluble vitamin in human body, the main function of vitamin D (VD) is mediated by its receptor. In the past decade, VD has drawn gradual and consistent attention from the scientific community and health professionals. According to epidemiological survey, approximately one billion people are under the state of vitamin D insufficiency or deficiency in the world. This phenomenon is also very common in China. By participating in calcium and phosphorus absorption from GIT, VD stands as a very important functional immune regulator. It plays a vital role in modulating both innate and adaptive immune responses, mainly through the modulation of growth, differentiation and function of a variety of immune cells, and the influence of secretion of cytokines and antimicrobial peptides. VD deficiency and pediatric diseases such as acute lower respiratory infection and asthma are associated with not only pediatric skeletal disorders (including nutritional rickets?osteomalacla?and osteoporosis), but also pediatric non-skeletal disorders, such as mortality rate, cardiovascular disorders and mortality?metabolic syndrome (including obesity?impaired glucose tolerance (IGT), diabetes mellitus, lipid metabolism disorders and hypertension), cancer?infection?allergy and asthma, neurological and mental diseases?autoimmune diseases?and chronic kidney diseases. Although VD treatment of skeletal disorders has been widely recognized?its efficacy and long-term effect on non-skeletal disorders is not clear. Hence, for the benefit of general children and their families, aim of the present review is to determine some convincing facts of evidence-based medicine about Chinese children, and to discuss certain reasonable, right and effective measures to prevent VD deficiency thereby reducing the risk of rickets.
Alreshidi, International Current Pharmaceutical Journal, December 2015, 5(1): 5-8
Downloads
108
191
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- The journal holds copyright and publishes the work under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).